Keurig Dr Pepper beats sales estimates, posts strong forecast on higher prices

Go back to Keurig Dr Pepper beats sales estimates, posts strong forecast on higher prices

Here's why Morgan Stanley sees 'plenty of upside left' in this well-known drink company

July 28, 2023 2:24 PM EDT

While the stock may be down almost 5% in 2023, Morgan Stanley analyst Dara Mohsenian reiterated a buy rating and raised the price target for a well-known drink company.

In fact, he told investors there is "plenty of upside left" in Nasdaq-listed Keurig Dr Pepper Inc. (NASDAQ: KDP), with the stock hitting an inflection point. The analyst lifted the firm's price target for the stock to $39 from $36... More